← Open Payments lookup

SAARAH ALKHAIRY: Open Payments

NPI 1104440361 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,091 in 51 payments from 10 companies in 2025. Trend: 2023 $1,564 · 2024 $873 · 2025 $2,091

Food & beverage: $2,091
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.21$526
Teva Pharmaceuticals USA, Inc.5$419
ABBVIE INC.3$267
Neurocrine BioSciences, Inc.6$221
Alkermes, Inc.9$171
Janssen Pharmaceuticals, Inc2$146
Axsome Therapeutics, Inc.1$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Vanda Pharmaceuticals Inc.2$42
Otsuka Pharmaceutical Development & Commercialization, Inc.1$31

Products named: COBENFY, UZEDY, VRAYLAR, INGREZZA, ARISTADA, Auvelity, CAPLYTA, SPRAVATO.

Industry payments across IL — which companies pay providers there.